SCIENCES VICE PRESIDENT, DEVELOPMENT, DENALI THERAPEUTICS
Palo Alto, California, United States
Dolo Diaz is Sr Vice President and Head of Development Sciences at Denali Therapeutics. In this role she leads groups that include clinical biomarker assay development and clinical pharmacology, which play a critical role in the development of biomarker endpoints for clinical decision making. Dolo is a seasoned drug developer with 20 years of experience in roles of increasing responsibility at Genentech and Denali Therapeutics. Dolo holds a PhD from the University of Washington.
1:45 PM - 2:45 PM (PDT)
Wednesday, June 15